The potential impact of pharmacogenetic testing on medication adherence
about
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectivesPharmacogenomics in diverse practice settings: implementation beyond major metropolitan areasPharmacogenomics of statins: understanding susceptibility to adverse effectsChallenges to integrating pharmacogenetic testing into medication therapy managementPilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics.Metformin pharmacogenomics: current status and future directions.Implementation and utilization of genetic testing in personalized medicine.Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral responseGenetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients.Nurses' communication of pharmacogenetic test results as part of discharge careAntidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools.Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy ChainsPrevalence of clinically actionable genotypes and medication exposure of older adults in the community.Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds.Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies.Clinical pharmacogenomics: patient perspectives of pharmacogenomic testing and the incidence of actionable test results in a chronic disease cohort.Pharmacogenetic tests yield bonus benefit: better drug adherence.
P2860
Q26741009-D3EB0C1F-CC49-4011-911B-F4F7E691A448Q27335306-3B36D011-8A74-48F1-97BD-A9C1D24FDD72Q28079822-F4CFC9AE-C8AC-415F-923F-8246D3904135Q28082835-622F0591-CCA4-4857-A3C8-21D4037D609CQ30612258-BD21A47E-79D2-422B-B0FE-94FA0DF67409Q33613526-865B37C8-795A-4C34-91CE-B398991264B2Q33959731-8D81EEDE-E47D-4CAF-84F2-83E4D6E4972AQ34147916-8B219E73-FCB6-4695-88C5-3D159088947EQ34173696-D9F89FE0-6783-4D5C-A408-77A606530BFFQ34683910-5CEEB86C-6471-46E3-A580-4A3288031556Q35317242-3E50A633-8344-49EA-AF84-FF1B1CCEC688Q36274662-E4923AAF-5F11-4C23-88A4-11B8FD13E82DQ37290806-D8988ED2-0D98-42AA-9449-A2FD81B6C03BQ37626738-98353046-76F9-4685-AE82-4222AFB68A61Q38248763-0F48C72B-B006-4F29-85BC-8B63C6D72BFFQ40759624-0084BFD2-3846-43C2-987F-CCB4D30F8C7DQ47205471-78A78367-F2DE-4162-8953-E661A04943F5Q54645555-E436A626-C22B-4109-8EEC-68423FBE6FD4
P2860
The potential impact of pharmacogenetic testing on medication adherence
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The potential impact of pharmacogenetic testing on medication adherence
@en
The potential impact of pharmacogenetic testing on medication adherence.
@nl
type
label
The potential impact of pharmacogenetic testing on medication adherence
@en
The potential impact of pharmacogenetic testing on medication adherence.
@nl
prefLabel
The potential impact of pharmacogenetic testing on medication adherence
@en
The potential impact of pharmacogenetic testing on medication adherence.
@nl
P2860
P356
P1476
The potential impact of pharmacogenetic testing on medication adherence
@en
P2093
N M A LaPointe
P2860
P2888
P304
P356
10.1038/TPJ.2013.33
P577
2013-09-03T00:00:00Z
P5875
P6179
1002709172